Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Fat LossMuscle BuildingInjury HealingAnti-AgingCognitive EnhancementSleep OptimizationImmune SupportGut HealingSkin RejuvenationSexual Health
Peptides
Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PNC-27
Cancer Research
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 32
Back to Home

Healing & Recovery Protocol

BPC-157Complete Dosing & Administration Guide

The "Wolverine peptide" known for its remarkable healing properties across tendons, ligaments, muscles, and the gut.

Dose Range

250-500mcg

Frequency

Once daily

Route

Subcutaneous injection

Cycle Length

4-6 weeks

Dosing

How much
do I take?

Starting Dose

250 mcg

Frequency

Once daily

Duration

1-2 weeks

Start here to assess tolerance. Can split into AM/PM if preferred.

Standard Dose

250-500 mcg

Frequency

Twice daily

Duration

4-6 weeks

Most common protocol. Split doses morning and evening for best results.

Advanced Dose

500 mcg

Frequency

Twice daily

Duration

6-8 weeks

For experienced users or severe injuries. Higher doses not shown to improve outcomes significantly.

Timing

Best time to take

Administer at a consistent time each day. Consistency matters more than the specific time of day.

With food?

Food timing does not significantly affect absorption for injectable peptides.

If stacking

If combining BPC-157 with other peptides, space administrations by 15-30 minutes. Consult your healthcare provider before combining with prescription medications.

Adjusting Your Dose

Increase if

  • +Current dose is well-tolerated for 2+ weeks
  • +Desired effects not yet noticeable
  • +Healthcare provider recommends dose increase

Decrease if

  • -Side effects become bothersome or persistent
  • -Desired effects achieved at lower dose
  • -Healthcare provider recommends reduction

Signs of right dose

  • Noticeable improvement in target symptoms
  • Good tolerance with minimal side effects
  • Consistent positive response between doses

Dosing Calculator

Calculate Your Exact Dose

1
2
3
4

Step 1: Peptide Weight

Find the weight printed on your peptide vial label

Look here!

The weight is on the label

Peptide vial
5mg

Select Weight

mg

Look for a number followed by 'mg' on the vial label (e.g., 5mg, 10mg)

Administration

How do I
use it?

Reconstitution

What you need

  • Bacteriostatic water (BAC water)
  • Insulin syringes (29-31 gauge)
  • Alcohol swabs
  • Sharps container

Example

If using a standard vial, add bacteriostatic water to achieve your desired concentration. For example, adding 2mL of BAC water to a vial allows precise dosing with an insulin syringe.

Draw up the appropriate volume based on your reconstitution ratio. Consult dosing charts for exact volumes corresponding to 250-500 mcg doses.

Injection

Route

Subcutaneous injection (into the fatty tissue just under the skin)

Best sites

  • Lower abdomen (2 inches from navel)
  • Outer thigh (middle third)
  • Back of upper arm

Technique

  • 1.Wash hands and prepare clean workspace
  • 2.Clean injection site with alcohol swab
  • 3.Draw correct dose into insulin syringe
  • 4.Pinch skin and insert needle at 45-90 degree angle
  • 5.Inject slowly, withdraw needle
  • 6.Apply gentle pressure—do not rub
  • 7.Dispose of syringe in sharps container
Full Injection Guide

Storage

Before reconstitution

Store in refrigerator at 36-46°F (2-8°C). Keep in original packaging to protect from light. Do not freeze.

After reconstitution

Store reconstituted solution in refrigerator at 36-46°F (2-8°C). Use within 30 days. Do not freeze reconstituted solution.

Signs of degradation

  • Solution appears cloudy or discolored
  • Visible particles or precipitates in solution
  • Solution has changed color from original appearance
  • Vial has been exposed to temperatures above 77°F (25°C) for extended periods

Sample Daily Schedule

Morning (8:00 AM)

250mcg injection

Site: Near injury or abdomen

Administer via subcutaneous injection in the morning for consistency. Inject near the site of injury for optimal localized healing effects, or in the abdomen for systemic benefits.

Evening (8:00 PM)

250mcg injection

Site: Rotate from morning

Duration: Continue for 4-6 weeks. Then: 2-4 week break before restarting if needed.

Safety

Is it
safe?

Safety Profile

BPC-157 is a gastric pentadecapeptide with strong preclinical evidence from extensive animal studies spanning over 25 years of research. Critical limitation: BPC-157 has NOT completed Phase 3 human clinical trials. No FDA approval exists. Safety data comes primarily from rat and mouse studies, with only limited Phase 1-2 human data. Animal studies show no toxicity at therapeutic doses, but human data is insufficient for regulatory approval. The peptide is unregulated, and no standardized manufacturing or quality control requirements exist for research compounds. Individual responses may vary significantly, and serious medical supervision is essential before use, particularly if you have gastrointestinal conditions, take medications, or have pre-existing medical conditions.

BPC-157's evidence base is categorized as 'Strong preclinical' based on extensive rat models demonstrating accelerated healing across multiple tissue types including tendon, ligament, muscle, and GI mucosa. However, no completed Phase 3 human clinical trials exist. Published human data is limited to a small number of early-phase studies and case reports. Manufacturing quality varies significantly between suppliers as the compound is not regulated by the FDA.

Common Side Effects

Experienced by some users

Injection site redness

Usually resolves in 30-60 minutes

Management: Rotate sites, ice if needed

Mild nausea

Typically only first few doses

Management: Take with food, reduce dose temporarily

Dizziness

Rare, usually with higher doses

Management: Reduce dose, stay hydrated

Less Common

  • Headache
  • Fatigue
  • Hot/cold sensations

These typically resolve with continued use or dose adjustment.

Stop and Seek Help If

  • ×If you experience severe or persistent injection site reactions or signs of infection
  • ×If you develop signs of an allergic reaction such as difficulty breathing, swelling, or severe rash
  • ×If healing progress plateaus after 6+ weeks of continuous use, indicating need for reassessment or alternative approaches

Always consult with a healthcare provider before discontinuing BPC-157, especially if used for active injury recovery. Do not stop abruptly without medical guidance as this may impact healing outcomes.

Interactions

With other peptides

  • TB-500
  • GHK-Cu
  • CJC-1295 + Ipamorelin

With medications

  • !Blood Thinners - Blood Thinners (Warfarin
  • !etc.) - etc.)
  • !NSAIDs - NSAIDs (Ibuprofen

With supplements

  • Vitamin D3 - Generally safe and may support overall health
  • Magnesium - Generally safe and may enhance peptide absorption

Want the Full Picture?

View the complete BPC-157 research profile including mechanism of action, clinical studies, effectiveness timeline, and FAQ.

View Full BPC-157 Profile

Medical Disclaimer

BPC-157 is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare provider before starting any new supplement or treatment protocol.

Last updated: 2/8/2026

BPC-157 Protocol — Complete Dosing & Administration Guide | Peptide Initiative